Arrowhead Pharmaceuticals Inc
LSE:0HI3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arrowhead Pharmaceuticals Inc
LSE:0HI3
|
US |
|
O
|
Optrontec Inc
KOSDAQ:082210
|
KR |
|
Barito Renewables Energy PT Tbk
OTC:BENGF
|
ID |
|
S
|
Smoore International Holdings Ltd
OTC:SMORF
|
CN |
|
DKSH Holding AG
OTC:DKSHF
|
CH |
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
D
|
Duke Energy Corp
XMUN:D2MN
|
US |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
D
|
Duke Energy Corp
DUS:D2MN
|
US |
|
Equinor ASA
OTC:STOHF
|
NO |
|
Equinor ASA
OSE:EQNR
|
NO |
Intrinsic Value
Is 0HI3 undervalued or overvalued?
See the intrinsic value estimate for Arrowhead Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Arrowhead Pharmaceuticals Does
Arrowhead Pharmaceuticals is a biotechnology company that designs medicines based on RNA interference, a way to turn down the production of harmful proteins inside the body. Its main work is developing drug candidates for diseases such as rare genetic disorders, liver-related conditions, and other illnesses where reducing a specific target protein may help patients.
- Headquarters
- United States of America US
- Employees
- 711
- IPO date
- Dec 14, 1993
Revenue & Expenses Breakdown
Arrowhead Pharmaceuticals Inc
Earnings Waterfall
Arrowhead Pharmaceuticals Inc
The intrinsic value for Arrowhead Pharmaceuticals Inc (0HI3) under the Base Case is hidden USD.
Compared with the current market price of 61.9 USD, the stock appears hidden.
